ABEONA THERAPEUTICS INC. Current Assets
ABEONA THERAPEUTICS INC. (ABEO) had Current Assets of $164.58 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $164.58M.
- 2026-03-31: Assets, Current $182.99M.
- 2025-12-31: Assets, Current $204.91M.
- 2025-09-30: Assets, Current $216.13M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $164.58M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $182.99M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $204.91M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $216.13M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $232.26M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $88.12M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $100.85M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $112.66M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $125.90M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $66.72M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $55.74M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $57.26M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $44.04M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $42.84M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $53.10M 10-K · filed 2024-03-18 | |
| 2022-09-30 | $25.50M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $30.30M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $39.20M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $56.29M 10-K · filed 2023-03-29 | $55.40M 10-K · filed 2022-03-31 |
| 2021-09-30 | $67.91M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $78.88M 10-Q · filed 2021-07-28 | |
| 2021-03-31 | $88.60M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $97.74M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $104.56M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $108.80M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $118.76M 10-Q · filed 2020-05-06 | |
| 2019-12-31 | $132.39M 10-K · filed 2021-03-24 | |
| 2019-09-30 | $49.59M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $64.89M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $71.72M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $88.85M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $114.55M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $121.83M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $134.15M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $140.59M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $58.40M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $59.27M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $63.82M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $69.42M 10-K · filed 2018-03-16 | |
| 2016-09-30 | $31.95M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $34.62M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $37.84M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $40.57M 10-K · filed 2017-03-30 | |
| 2015-09-30 | $43.69M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $30.96M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $8.19M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $11.55M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $244.00K 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $203.00K 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $440.00K 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $575.00K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $1.04M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $2.35M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $1.67M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $1.68M 10-K · filed 2014-03-26 | |
| 2012-09-30 | $851.00K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $2.03M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $2.77M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $3.31M 10-K · filed 2013-03-20 | |
| 2011-09-30 | $1.69M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $4.47M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $8.12M 10-K · filed 2012-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |